Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Status Withdrawn

Clinical Trial Summary

100 subjects who have a family history of pancreatic cancer (PC), or known genetic syndromes associated with increased risk of pancreatic cancer, will be followed for five years. This data will be used to determine the pancreatic cancer and precancerous lesion detection rate in High Risk Individuals (HRIs). Subjects may agree to annual imaging and annual biomarkers or to biomarkers only.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Ataxia Telangiectasia
BRCA1 Gene Mutation
BRCA2 Gene Mutation
Colorectal Neoplasms
Colorectal Neoplasms, Hereditary Nonpolyposis
Dysplastic Nevus Syndrome
Familial Atypical Mole-Malignant Melanoma Syndrome
Hereditary Pancreatitis
Melanoma
Neoplasms
Pancreatic Neoplasms
Pancreatitis
Pancreatitis, Chronic
Peutz-Jegher's Syndrome
Peutz-Jeghers Syndrome
Skin Neoplasms
Syndrome
Telangiectasis

Clinical Trial Details

NCT number	NCT02309632
Study type	Interventional
Source	University of Arkansas
Contact
Status	Withdrawn
Phase	N/A
Start date	November 2015
Completion date	July 19, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04085055` - Fine Needle Biopsy of Solid Pancreatic Mass Lesions	N/A
Recruiting	`NCT01950572` - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Terminated	`NCT00529113` - Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer	Phase 1
Recruiting	`NCT05351983` - Patient-derived Organoids Drug Screen in Pancreatic Cancer	N/A
Recruiting	`NCT04809935` - EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy	Phase 4
Recruiting	`NCT05481476` - Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer	Phase 2
Not yet recruiting	`NCT04652271` - International Pancreatic Surgery Outcomes Study - PancreasGroup.Org
Active, not recruiting	`NCT02950064` - A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations	Phase 1
Completed	`NCT03054987` - Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction	N/A
Completed	`NCT02909530` - Comparison Between Olympus EZ Shot 3Plus 19G and EZ Shot 2 19G in EUS-guided FNB of Solid Pancreatic Masses	N/A
Completed	`NCT02374411` - Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients	N/A
Completed	`NCT01770405` - Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract	N/A
Terminated	`NCT01313416` - Gemcitabine and CT-011 for Resected Pancreatic Cancer	Phase 2
Terminated	`NCT01515046` - Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer	Phase 2
Enrolling by invitation	`NCT01465425` - Extracolonic Findings on Computed Tomography (CT) Colonography
Terminated	`NCT01434459` - Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin	Phase 1
Completed	`NCT00985777` - Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia	Phase 1
Completed	`NCT00385177` - Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors	Phase 1
Recruiting	`NCT00178763` - Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer	Phase 2
Completed	`NCT00136669` - Acupuncture For Pancreatic Cancer Pain	Phase 3